Evaluation of safety, side effects and how the drug CHF6467 administrated via intranasal route is absorbed, modified and removed in healthy subjects.

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-521455-23-00

Acronym

CLI-06467AC1-02

Enrollment

Registered

2025-08-05

Start date

2025-09-11

Completion date

Unknown

Last updated

2026-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Hypoxic-Ischemic Encephalopathy (HIE)

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Bulgaria

None listed

Source: EU CTIS · Data processed: Feb 4, 2026